OTC · CNER
BioEnergy Development Inc.
$0.00$0.00 (0.0%)
BioEnergy Development Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.33% below the high.
Loading market information…
OTC · FITY · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Fifty 1 Labs, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fifty 1 Labs, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research and aims to develop a telehealth platform for personalized peptide therapies. Formerly involved in automotive finance, the company is now pursuing growth in the functional medicine and life sciences sectors.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:59 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
BioEnergy Development Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.33% below the high.
$0.05$0.00 (0.0%)
S-Ventures Plc: Financial Services · Asset Management.
$0.00$0.00 (0.0%)
FinCanna Capital Corp.’s quoted price sits in the upper half of its reported 52-week range, 19.44% below the high.
$0.02$0.00 (0.0%)
China Solar & Clean Energy Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.98% below the high.
$0.07$0.00 (0.0%)
Innovative Holdings Alliance, Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.48% below the high.
$0.00$0.00 (0.0%)
Towne Bancorp, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Atlantis Technology Group’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Sunvault Energy, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
